1-2 of 2
Colleen Harvey
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Lenalidomide, Bortezomib, Pegylated Liposomal Doxorubicin, and Dexamethasone in Newly Diagnosed Multiple Myeloma: Updated Results of Phase I/II MMRC Trial.

Andrzej J. Jakubowiak, MD, PhD, Donna E. Reece, Craig C. Hofmeister, MD, Sagar Lonial, MD, Todd M. Zimmerman, MD, Erica L. Campagnaro, MD, Robert L. Schlossman, MD, Jacob Laubach, Noopur Raje, MD, Tara Anderson, PA, Kent Griffith, Melissa Hill, Colleen Harvey, Akari M. Dollard, Sandra Wear, Jennifer Barrickman, Craig Tendler, MD, Dixie-Lee Esseltine, MD, Susan L. Kelley, MD, Mark S. Kaminski, MD, Kenneth C. Anderson, Paul G. Richardson, MD
Journal: Blood
Blood (2009) 114 (22): 132.
https://doi.org/10.1182/blood.V114.22.132.132
Published: 2009
Journal Articles

Phase I Results of Perifosine (KRX-0401) in Combination with Lenalidomide and Dexamethasone in Patients with Relapsed or Refractory Multiple Myeloma (MM)

Andrzej Jakubowiak, MD, PhD, Paul Richardson, MD, Todd M. Zimmerman, MD, Melissa Alsina, MD, Jonathan L. Kaufman, MD, Colleen Harvey, Christine Brozo, PA, Tara Kendall, PA, Amanda McAllister, Teru Hideshima, MD, PhD, Peter Sportelli, Lesa Gardner, RN, Kenneth C. Anderson, MD, Kathy Giusti, MBA
Journal: Blood
Blood (2008) 112 (11): 3691.
https://doi.org/10.1182/blood.V112.11.3691.3691
Published: 2008